We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $8.21B
1-Year Est. Return 28.81%
This Fund
S&P 500
This Quarter Est. Return
-0.18%
1 Year Est. Return
+28.81%
3 Year Est. Return
+92.54%
5 Year Est. Return
+114.67%
10 Year Est. Return
+429.8%
AUM
$5.34B
AUM Growth
-$237M
Cap. Flow
-$130M
Cap. Flow %
-2.43%
Top 10 Hldgs %
17.36%
Holding
1,615
New
114
Increased
629
Reduced
604
Closed
130

Top Buys

Rank Stock Value
1
XYLD icon
Global X S&P 500 Covered Call ETF
XYLD
+$49.5M
2
GXO icon
GXO Logistics
GXO
+$10.2M
3
GSY icon
Invesco Ultra Short Duration ETF
GSY
+$9.29M
4
MINT icon
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
+$7.06M
5
C icon
Citigroup
C
+$6.92M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$17.6M
2
AAPL icon
Apple
AAPL
+$16.6M
3
NVDA icon
NVIDIA
NVDA
+$14.2M
4
IDXX icon
Idexx Laboratories
IDXX
+$13.7M
5
XPO icon
XPO
XPO
+$13.2M

Sector Composition

Rank Sector Weight
1 Technology 18.05%
2 Financials 11.09%
3 Healthcare 10.47%
4 Consumer Discretionary 9.45%
5 Industrials 8.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DNTH icon
1426
Dianthus Therapeutics
DNTH
$6.16B
$146K ﹤0.01%
1,250
– –
PAA icon
1427
Plains All American Pipeline
PAA
$17.5B
$145K ﹤0.01%
14,238
-79,482
-85% -$790K
TUFN
1428
DELISTED
Tufin Software Technologies Ltd.
TUFN
$144K ﹤0.01%
14,600
-5,100
-26% -$53K
IBRX icon
1429
ImmunityBio
IBRX
$7.8B
$143K ﹤0.01%
+14,720
New +$162K
JRO
1430
DELISTED
Nuveen Floating Rate Income Opportunty Fund
JRO
$142K ﹤0.01%
14,270
+69
+0.5% +$676
BCS icon
1431
Barclays
BCS
$93.4B
$140K ﹤0.01%
13,536
+3,426
+34% +$34.1K
NAGE
1432
Niagen Bioscience
NAGE
$264M
$139K ﹤0.01%
22,210
– –
MITT
1433
TPG Mortgage Investment Trust
MITT
$225M
$136K ﹤0.01%
11,826
-503
-4% -$5.5K
FRO icon
1434
Frontline
FRO
$8.7B
$135K ﹤0.01%
+14,430
New +$114K
MBIO icon
1435
Mustang Bio
MBIO
$4.5M
$125K ﹤0.01%
62
-143
-70% -$307K
SHO icon
1436
Sunstone Hotel Investors
SHO
$2.18B
$124K ﹤0.01%
10,404
– –
MGF
1437
Aberdeen Government Markets Income Fund
MGF
$91.6M
$122K ﹤0.01%
28,131
+148
+0.5% +$652
BFLY icon
1438
Butterfly Network
BFLY
$2.14B
$117K ﹤0.01%
11,200
– –
PIM
1439
Franklin Master Intermediate Income Trust
PIM
$149M
$117K ﹤0.01%
28,700
-18,500
-39% -$76.3K
NSL
1440
DELISTED
NUVEEN SENIOR INCM FD
NSL
$117K ﹤0.01%
20,000
-9,500
-32% -$55.2K
DNA icon
1441
Ginkgo Bioworks
DNA
$528M
$116K ﹤0.01%
+250
New +$122K
INSG icon
1442
Inseego
INSG
$111M
$113K ﹤0.01%
1,700
– –
PGEN icon
1443
Precigen
PGEN
$2.12B
$113K ﹤0.01%
22,700
– –
PPT
1444
Franklin Premier Income Trust
PPT
$323M
$113K ﹤0.01%
24,700
-13,500
-35% -$62.2K
NGNE icon
1445
Neurogene
NGNE
$670M
$110K ﹤0.01%
760
+51
+7% +$7.81K
ATXS
1446
DELISTED
Astria Therapeutics
ATXS
$108K ﹤0.01%
12,249
+1,999
+20% +$19.2K
KALA icon
1447
KALA BIO
KALA
$13.6M
$107K ﹤0.01%
16
+4
+33% +$34.5K
MNKD icon
1448
MannKind Corp
MNKD
$1.27B
$104K ﹤0.01%
23,800
+3,000
+14% +$13.5K
PSEC icon
1449
Prospect Capital
PSEC
$1.08B
$102K ﹤0.01%
13,222
– –
MFM
1450
Aberdeen Municipal Income Fund
MFM
$222M
$101K ﹤0.01%
14,497
-6,500
-31% -$46.9K
56 57
58
59 60

Similar funds

LGF
LGT Group Foundation Vaduz, Liechtenstein $8.19B AUM 27.7% 1-Year Est. Return
CCM
Causeway Capital Management Los Angeles, California $8.15B AUM 29.28% 1-Year Est. Return
CL
Choreo LLC Rockford, Illinois $8.15B AUM 20.12% 1-Year Est. Return
WJWM
Williams Jones Wealth Management New York $8.14B AUM 19.32% 1-Year Est. Return
WA
Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.85% 1-Year Est. Return
CCM
Coldstream Capital Management Bellevue, Washington $8.12B AUM 17.95% 1-Year Est. Return
AIM
Allen Investment Management New York $8.09B AUM 16.78% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

Oppenheimer & Co's Q3 2021 Portfolio in Review

As of Q3 2021, Oppenheimer & Co held 1,615 positions worth $5.34B, down 4.2% from $5.58B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Oppenheimer & Co's Q3 2021 filing shows 114 new, 629 increased, 604 reduced and 130 closed positions. Its largest new stake was Global X S&P 500 Covered Call ETF: 1,004,600 shares worth $488K. The largest sale was Microsoft, an estimated $17.6M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.

  • Oppenheimer & Co's largest Q3 2021 buy was Global X S&P 500 Covered Call ETF: 1,004,600 shares worth $488K.
  • Oppenheimer & Co added most to Invesco Ultra Short Duration ETF in Q3 2021, an estimated $9.29M increase.
  • Oppenheimer & Co's biggest Q3 2021 reduction was Microsoft, cutting an estimated $17.6M.
  • Oppenheimer & Co fully exited Pricesmart in Q3 2021, selling an estimated $6.18M.
  • Oppenheimer & Co's ten largest holdings make up 17% of its $5.34B portfolio in Q3 2021.
  • Oppenheimer & Co opened 114 new positions and closed 130 in Q3 2021.
  • Oppenheimer & Co's portfolio value fell 4.2% quarter-over-quarter to $5.34B.

Based on Oppenheimer & Co's 13F filing for Q3 2021, filed 12 Nov 2021.